Key facts
- Phylo (Commercial Services)’s last known valuation is $61.5M (Feb 2026).
- It has raised $13.5M; the latest was Seed Round ($13.5M) in Feb 2026.
- Notable investors include Andreessen Horowitz, SV Angel, Menlo Ventures, Hawktail, Conviction Partners — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Phylo (Commercial Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Phylo (Commercial Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phylo (Commercial Services)
Operator of an applied research lab intended to study agentic intelligence to accelerate discoveries for every biomedical scientist. The company offers a unified workspace where biologists can collaborate with agents to get more done, with rigor, and at scale, and analyze multi-omics data, enabling researchers to review tasks by scanning each step for hallucinations and factual mistakes.
- Sector
- Business Products and Services (B2B)
- HQ
- San Mateo, CA, United States
- Founded
- 2025
- Employees
- 9
- Website
- phylo.bio/
- Ownership
- Privately Held (backing)
Phylo (Commercial Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phylo (Commercial Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phylo (Commercial Services) in its N-PORT filings yet. We sweep new filings monthly.